Búsqueda | Portal de Búsqueda de la BVS Ecuador

1.

Complex decisions in managing HIV infection during pregnancy.

Vogler, Mary A; Singh, Harjot; Wright, Rodney.

Curr HIV/AIDS Rep ; 8(2): 122-31, 2011 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-21455746

2.

COVID-19 in Hospitalized Adults With HIV.

Stoeckle, Kate; Johnston, Carrie D; Jannat-Khah, Deanna P; Williams, Samuel C; Ellman, Tanya M; Vogler, Mary A; Gulick, Roy M; Glesby, Marshall J; Choi, Justin J.

Open Forum Infect Dis ; 7(8): ofaa327, 2020 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-32864388

3.

Acute MI with long-standing AIDS: a perfect storm of risk factors for premature coronary artery disease.

Vogler, Mary A.

AIDS Read ; 19(5): 196-200, 2009 May.

Artículo en Inglés | MEDLINE | ID: mdl-19554739

4.

Combination antiretroviral treatment for women previously treated only in pregnancy: week 24 results of AIDS clinical trials group protocol a5227.

Vogler, Mary A; Smeaton, Laura M; Wright, Rodney L; Cardoso, Sandra W; Sanchez, Jorge; Infante, Rosa; Moran, Laura E; Godfrey, Catherine; Demeter, Lisa M; Johnson, Victoria A.

J Acquir Immune Defic Syndr ; 65(5): 542-50, 2014 Apr 15.

Artículo en Inglés | MEDLINE | ID: mdl-24759064

5.

Severe headaches and cerebrovascular disease in a young man with perinatally acquired HIV infection.

Vogler, Mary A.

AIDS Read ; 18(7): 354-6, 362-5, 2008 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-18655312

6.

Pregnancy in a perinatally infected woman: preventing second-generation mother-to-child transmission of HIV.

Vogler, Mary A.

AIDS Read ; 17(11): 536-40, 2007 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-18167068

7.

A new heterogeneous liver mass in a patient with well-controlled HIV and HBV infection.

Vogler, Mary A.

AIDS Read ; 16(8): 393-6, 401-2, 2006 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-16933373

8.

Contraceptive efficacy of oral and transdermal hormones when co-administered with protease inhibitors in HIV-1-infected women: pharmacokinetic results of ACTG trial A5188.

Vogler, Mary A; Patterson, Kristine; Kamemoto, Lori; Park, Jeong-Gun; Watts, Heather; Aweeka, Francesca; Klingman, Karin L; Cohn, Susan E.

J Acquir Immune Defic Syndr ; 55(4): 473-82, 2010 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-20842042

9.

Update: preventing mother-to-child transmission of HIV.

Vogler, Mary A.

Curr HIV/AIDS Rep ; 3(2): 59-65, 2006 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-16608661

10.

Daily low-dose subcutaneous interleukin-2 added to single- or dual-nucleoside therapy in HIV infection does not protect against CD4+ T-cell decline or improve other indices of immune function: results of a randomized controlled clinical trial (ACTG 248).

Vogler, Mary A; Teppler, Hedy; Gelman, Rebecca; Valentine, Fred; Lederman, Michael M; Pomerantz, Roger J; Pollard, Richard B; Cherng, Deborah Weng; Gonzalez, Charles J; Squires, Kathleen E; Frank, Ian; Mildvan, Donna; Mahon, Laura F; Schock, Barbara.

J Acquir Immune Defic Syndr ; 36(1): 576-87, 2004 May 01.

Artículo en Inglés | MEDLINE | ID: mdl-15097300

Portal de Búsqueda de la BVS Ecuador

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Complex decisions in managing HIV infection during pregnancy.

COVID-19 in Hospitalized Adults With HIV.

Acute MI with long-standing AIDS: a perfect storm of risk factors for premature coronary artery disease.

Combination antiretroviral treatment for women previously treated only in pregnancy: week 24 results of AIDS clinical trials group protocol a5227.

Severe headaches and cerebrovascular disease in a young man with perinatally acquired HIV infection.

Pregnancy in a perinatally infected woman: preventing second-generation mother-to-child transmission of HIV.

A new heterogeneous liver mass in a patient with well-controlled HIV and HBV infection.

Contraceptive efficacy of oral and transdermal hormones when co-administered with protease inhibitors in HIV-1-infected women: pharmacokinetic results of ACTG trial A5188.

Update: preventing mother-to-child transmission of HIV.

Daily low-dose subcutaneous interleukin-2 added to single- or dual-nucleoside therapy in HIV infection does not protect against CD4+ T-cell decline or improve other indices of immune function: results of a randomized controlled clinical trial (ACTG 248).